• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Intercept: OCA-Bezafibrate Combo Data In PBC At EASL 2024

    GLOBENEWSWIRE

    Intercept Shows OCA-Bezafibrate Combo Impact On ALP, Metabolic Outcomes

    GLOBENEWSWIRE

    Intercept Announces Phase 2 Data Showing Significant Impact of OCA-Bezafibrate

    GLOBENEWSWIRE

    Intercept Presents New Data Showing Significant Impact of OCA-bezafibrate

    GLOBENEWSWIRE

    Intercept Announces New Data Showing Potential of Fixed-Dose Combination of OCA

    GLOBENEWSWIRE

    Intercept Announces First Patient Dosed in Phase 2 Study of OCA and Bezafibrate

    GLOBENEWSWIRE

    Intercept’s Phase II-ready Ocaliva/bezafibrate has mixed experts views

    CLINICALTRIALSARENA

    Anvisa Suspends the Import of All Pharmaceutical Raw Materials from Sinbiotik SA, Mexico

    ANVISA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.